CHULN - Hospital Pulido Valente

Lisbon 1769-001

1 studies enrolling now · 1 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation

Studies at this site

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now